In another study on chronic lymphocytic leukemia, the disialyl-T antigen on CD162 and CD45 was proven to inhibit NK cells via binding to Siglec-7 [141]. The gene discussed is PTPRC; the disease is B-cell chronic lymphocytic leukemia.